磁共振波谱评估胶质瘤IDH状态:神经诊断中波谱活检的新前沿
BACKGROUND: In the era of integrated genomic-histologic analysis of brain tumors, new biomarkers have been introduced as diagnostic, prognostic, and therapeutic indicators.…
要点
- 2HG-MRS可无创检测IDH突变胶质瘤中蓄积的2-羟基戊二酸,术前提供IDH状态信息。
- 澳大利亚初步研究纳入10例胶质瘤患者,2HG-MRS诊断敏感性和特异性均为100%。
- 作者建议将2HG-MRS整合到神经影像和神经肿瘤学的标准临床实践中。
核心结论
- 2HG-MRS检测的2HG在胶质瘤诊断中具有强预测作用,作者倡导将2HG-MRS整合到标准临床实践中。
主要发现
- 在该探索性研究中,2HG-MRS检测的敏感性和特异性均达到100%。
关键数值与推荐
- 2HG-MRS检测的敏感性为100%,特异性为100%。
临床怎么用
- 术前通过2HG-MRS无创检测IDH突变状态,可辅助胶质瘤诊断和治疗决策。
局限性
- 2HG-MRS技术仍具有技术挑战性,初步研究样本量仅10例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the era of integrated genomic-histologic analysis of brain tumors, new biomarkers have been introduced as diagnostic, prognostic, and therapeutic indicators. The analysis of the mutation in the isocitrate dehydrogenase (IDH) genes IDH1 and IDH2 has provided important diagnostic and prognostic information for patients affected by diffuse glioma (i.e., the presence of the mutation has been related to an increased survival rate). The reference standard of IDH mutation detection has been its assessment in surgical specimens, immunohistochemistry, and/or genetic sequencing. Knowing the IDH status information preoperatively would be of great importance, because it has been related to tumor progression and the response to treatment. The oncometabolite 2-hydroxyglutarate (2HG), accumulated in gliomas with IDH mutation status, can be detected in vivo using magnetic resonance spectroscopy (MRS). METHODS: The 2HG-MRS technique remains technically challenging. We have summarized the results of the first pilot study in Australia, which included 10 patients affected by glioma. The data recorded from May 2017 to November 2018 were analyzed. RESULTS: In our exploratory study, we reached a sensitivity and specificity of 100%, confirming the strong predictive role of 2HG, as detected using MRS, in the diagnosis of glioma. CONCLUSION: In the present study, we have focused on methodological tips and future perspectives of the technique in the neuroimaging and neuro-oncological scenario. We would advocate the integration of 2HG-MRS into standard clinical practice.
引用
- Di Ieva A, Magnussen JS, McIntosh J, et al. Magnetic Resonance Spectroscopic Assessment of Isocitrate Dehydrogenase Status in Gliomas: The New Frontiers of Spectrobiopsy in Neurodiagnostics. World Neurosurg. 2019. PMID: 31526886. doi:10.1016/j.wneu.2019.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。